论文信息 - Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators - 字舞流文

Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

K. Syrigos | H. Milionis | E. Michelakis | E. Giamarellos‐Bourboulis | K. Syrigos | T. Gkavogianni | P. Koufargyris | A. Karageorgos | K. Katrini | G. Poulakou | M. Kosmidou | M. Georgiopoulou | E. Klouras | I. Rapti | P. Panagopoulos | S. Artemi | P. Tsiamalos | A. Gravvani | G. Chrysos | K. Tsiakos | Antonios Tsakiris | G. Tsibris | P. Voutsinas | V. Petrakis | E. Vrentzos | C. Damoulari | V. Zarkada | C. Sidiropoulou | A. Papapostolou | D.-M. Myrodia | T. Nitsotolis | A. Tsakiris | P. Voutsinas | Panagiotis Koufargyris | Christina Damoulari | D. Myrodia | Chrysanthi Sidiropoulou | Anastasios Ioannidis | Vagia Zarkada | Sofia Artemi | Gerorgios Tsibris